CBD, or Cannabidiol as it is known, is a very prominent compound found in the cannabis plant. Unlike its other counterpart Δ9-THC, CBD is non-intoxicating, which means it does not produce the “high” associated with marijuana. Moreover, it boasts a high level of beneficial effects such as its anti-inflammatory, anxiolytic, antiemetic, and antipsychotic properties.
Nevertheless, as the consumption of CBD keeps increasing so also does the need for a very clear knowledge and understanding of its safety and compliance standards.
Also Read – Differentiating CBD: Marijuana, Cannabis, and Hemp Explained
Safety and Side Effects
CBD’s Safety Profile: Generally, CBD has been found to have a very favourable safety profile in humans. It has been used in high doses for the treatment of different kinds of conditions like epilepsy, psychotic disorders, dementia, diabetes, as well as nausea without causing intoxicating effects.
Common Side Effects: While CBD is known to be largely safe, consumers may experience side effects such as tiredness, diarrhea, and changes in appetite/weight. However, compared to other drugs used for the same medical conditions, CBD’s side effect profile seems much better.
Areas of Concern: Some important toxicological parameters have remained unexplored. For instance, there is yet to be research or study on CBD’s effect on hormones. There is also the need for more clinical trials with a larger number of participants to assess and determine chronic CBD administration effects.
Compliance with Regulations
CBD as a Novel Food: In recent years, CBD has been seen as a ‘novel food’ under food safety regulations. This then means any CBD food product, including food supplements, oils, and tinctures, requires pre-market authorization, including a risk assessment.
Ensuring Legitimate Sales: Pharmacies selling CBD ‘novel food’ products should always check the Food Standards Agency (FSA) database to make sure that the products they sell have either received or are undergoing market authorization. Very important. Unauthorized products should be promptly removed from shelves.
CBD Product Regulation: As at now January 2019, all CBD food products require authorization before they can be legally sold in Great Britain. No CBD extracts or isolates are currently authorized for sale in Great Britain. An essential part of any CBD novel food application is the product’s safety consideration. It is very important to consider the safety of the product and the security of consumers.
Toxicological Information: It is highly recommended that toxicological testing of CBD products be conducted, considering the EFSA guidelines on novel food applications. Testing might include a 90-day oral toxicity study and an also assessment of specific parameters in repeated-dose 28-day oral toxicity studies
Tips for Responsible CBD Consumption
Be Careful with ‘Novel Food’ Products: Because all CBD ‘novel food’ products go through a rigorous process before they are authorized, it is very important that users are informed of the latest update on the FSA database for any changes in the legal status of the products they consume.
- Stay Informed: If purchasing CBD products, particularly for ingestion, make sure that they are compliant with local regulations and have undergone very rigorous testing.
- Start Low and Go Slow: Do not start with a large dosage, start with a very lower dosage of CBD, and then you can choose to increase it with time. But before increasing it, you have to be sure that you are not experiencing any negative side effects because minimizes any kind of risk.
- Consult a Healthcare Professional: Before starting CBD, particularly if you’re on other medications, consult a healthcare professional to ensure safe consumption.
Also Read – Historical Uses of Industrial Hemp: From Ropes to The Building Materials
CBD without doubt offers numerous potential benefits, but it is crucial to be informed and be very cautious when introducing it into your regimen. Safety and strict adherence to local regulations ensure that you get the most out of your CBD experience.
Dr. Jason O’Donnell works at Holy Cross General Hospital. He is a General Practitioner with extensive experience in cardiology, geriatrics, adult medicine, and internal medicine. Dr. O’Donnell studied at the UCL Medical School and holds a Doctor of Medicine in London in the UK. He also completed an internal medicine internship at London Imperial College. From here he went on to complete a residency in internal medicine at St. George’s London University. He is currently practicing adult medicine, cardiology, geriatrics, and internal medicine at Holy Cross General Hospital. Before he performs any operation, he first assesses the patient’s medical goals and concerns. After the surgery, he monitors the recovery of the patient and makes adjustments to the treatment program, when necessary. Dr. O’Donnell is also a proud member of Health for Humanity where he volunteers his skills in medicine for people in need across the globe.
